Alivus Life Sciences Schedules Institutional Investor Meetings in Mumbai
Alivus Life Sciences Ltd 路 Intimation 路 08 Sept 2026, 4:09 am
Alivus Life Sciences Schedules Institutional Investor Meetings in Mumbai Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) will host in-person institutional investor and analyst meetings on 10th Sep'26 and 11th Sep'26 in Mumbai. The interactions will involve various mutual funds and institutions across group and one-on-one formats, subject to scheduling changes.
Original exchange filing (PDF)
More announcements from Alivus Life Sciences Ltd
- Enclosed please find herewith update on acquisition. 路 11 Nov 2026
- Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR), 2015. 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma Ltd 路 07 Nov 2026
- Please find attached herewith submission with respect to transcript of the earning call. 路 06 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor meeting. 路 04 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor Meet. 路 30 Oct 2026
- We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30, 2026 on the website of the Company. 路 30 Oct 2026
- Please find enclosed herewith intimation with respect to allotment of equity shares under "Employee Stock Option Scheme, 2021" 路 30 Oct 2026
